Phreesia faces securities class action
Analysis based on 12 articles · First reported May 19, 2026 · Last updated May 29, 2026
The class action lawsuit against Phreesia could negatively impact its stock price and investor confidence due to allegations of securities fraud. For Bronstein, Gewirtz & Grossman, LLC, a successful outcome could enhance its reputation and financial standing.
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Phreesia and its officers, alleging violations of federal securities laws. The lawsuit claims that Phreesia made materially false and misleading statements between May 8, 2025, and March 30, 2026, regarding slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors who purchased Phreesia securities during this period are encouraged to join the lawsuit, with a deadline of July 13, 2026, to request lead plaintiff status. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, seeking to recover damages for investors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard